Bearish flow noted in Iovance Biotherapeutics with 1,107 puts trading, or 2x expected. Most active are Jul-24 8 puts and Jan-25 9 calls, with total volume in those strikes near 1,100 contracts. The Put/Call Ratio is 1.81, while ATM IV is up over 14 points on the day. Earnings are expected on August 6th.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IOVA:
- Iovance Biotherapeutics call volume above normal and directionally bullish
- Iovance Biotherapeutics Submits Marketing Authorization Application to European Medicines Agency for Lifileucel in Advanced Melanoma
- Iovance Biotherapeutics submits MAA to EMA for lifileucel
- Jefferies healthcare analyst holds an analyst/industry conference call
- Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)